
Pregabalin (75mg) + Methylcobalamin (1500mcg)
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Medical applications
Mecoblend-PSR Tablet is a combination pharmaceutical formulation containing Methylcobalamin 1500 mcg and Pregabalin 75 mg, indicated for the management of neuropathic pain and associated neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety symptoms. The synergistic effect of these two components provides effective relief from peripheral neuropathy, diabetic neuropathy, postherpetic neuralgia, and other neuropathic conditions. Mecoblend-PSR is also beneficial in improving nerve conduction velocity and reducing symptoms such as burning, tingling, numbness, and shooting pain. The recommended dosage should be individualized based on clinical response and tolerability, with caution advised in patients with renal impairment. Common adverse effects may include dizziness, somnolence, gastrointestinal disturbances, and allergic reactions. Mecoblend-PSR Tablet should be used under medical supervision, with attention to contraindications such as hypersensitivity to either component. This combination therapy offers a comprehensive approach to neuropathic pain management by addressing both symptomatic relief and underlying nerve repair mechanisms.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Mecoblend-PSR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Mecoblend-PSR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Mecoblend-PSR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mecoblend-PSR Tablet may be needed. Please consult your doctor.
Exercise Caution
Mecoblend-PSR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Mecoblend-PSR Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mecoblend-PSR Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Mecoblend-PSR Tablet

Methylcobalamin (1500mcg) + Pregabalin (75mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Medical applications
Mecoblend-PSR Tablet is a combination pharmaceutical formulation containing Methylcobalamin 1500 mcg and Pregabalin 75 mg, indicated for the management of neuropathic pain and associated neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety symptoms. The synergistic effect of these two components provides effective relief from peripheral neuropathy, diabetic neuropathy, postherpetic neuralgia, and other neuropathic conditions. Mecoblend-PSR is also beneficial in improving nerve conduction velocity and reducing symptoms such as burning, tingling, numbness, and shooting pain. The recommended dosage should be individualized based on clinical response and tolerability, with caution advised in patients with renal impairment. Common adverse effects may include dizziness, somnolence, gastrointestinal disturbances, and allergic reactions. Mecoblend-PSR Tablet should be used under medical supervision, with attention to contraindications such as hypersensitivity to either component. This combination therapy offers a comprehensive approach to neuropathic pain management by addressing both symptomatic relief and underlying nerve repair mechanisms.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Mecoblend-PSR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Mecoblend-PSR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Mecoblend-PSR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mecoblend-PSR Tablet may be needed. Please consult your doctor.
Exercise Caution
Mecoblend-PSR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Mecoblend-PSR Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mecoblend-PSR Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Mecoblend-PSR Tablet















